Citations

Clear

391 citation(s) found for "Bi, Chun".

Approach for fast time–frequency analysis
Cheng, Chun Hing , Pradhan, Pyari Mohan , Mitchell, J. Ross

Mayo Clinic

IET Signal Processing | October 23, 2013 | Volume: 8 | Issue: 4 | Pages: 360-372

10.1049/iet-spr.2013.0157 Get It

S ‐transform (ST) is a time–frequency representation (TFR) that is popularly used in a variety of applications, but prohibitive in both storage and computation for large time series. This study proposes a one‐dimensional fast time–frequency transform (FTFT‐1D) which generates a highly compressed form of the ST directly, without the need to compute the complete ST matrix initially and compress it subsequently. The compression technique used in the FTFT‐1D helps in storage, transmission and visualisation of the ST. The FTFT‐1D encodes the TFR information uniformly and finds the local spectrum instantaneously and accurately. It is useful for real‐time applications such as monitoring, control and filtering. In addition, the FTFT‐1D is memory efficient, robust and adaptive in nature.
A Polymeric Fastener Can Easily Functionalize Liposome Surfaces with Gadolinium for Enhanced Magnetic Resonance Imaging
Smith, Cartney E., Shkumatov, Artem, Withers, Sarah G., Yang, Binxia , Glockner, James F., Roy, Edward J. , Wong, Chun‐Ho , Zimmerman, Steven C. , Kong, Hyunjoon , Misra, Sanjay , Misra, Sanjay , Kong, Hyunjoon , Misra, Sanjay

Mayo Clinic

ACS Nano | October 1, 2013 | Volume: 7 | Issue: 11 | Pages: 9599-9610

10.1021/nn4026228 | PMID 24083377 Get It

Impact of peri‐operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder
Kluth, Luis A. , Xylinas, Évanguelos , Rieken, Malte, Ghouayel, Maya El, Sun, Maxine , Karakiewicz, Pierre I. , Boorjian, Stephen A. , Lee, Richard K. , Briganti, Alberto , Fisch, Margit , Scherr, Douglas S. , Lotan, Yair , Chun, Felix K.‐H. , Rouprêt, Morgan , Shariat, Shahrokh F.

Mayo Clinic

BJU International | September 5, 2013 | Volume: 113 | Issue: 3 | Pages: 393-398

10.1111/bju.12439 | PMID 24053618 Get It

Objective To determine the association between peri‐operative blood transfusion ( PBT ) and oncological outcomes in a large multi‐institutional cohort of patients undergoing radical cystectomy ( RC ) for urothelial carcinoma of the bladder ( UCB ). Patients and Methods We conducted a retrospective analysis of 2895 patients treated with RC for UCB . Univariable and multivariable C ox regression models were used to analyse the effect of PBT administration on disease recurrence, cancer‐specific mortality, and any‐cause mortality. Results Patients' median (interquartile range [ IQR ]) age was 67 (60, 73) years and the median ( IQR ) follow‐up was 36.1 (15, 84) months. Patients who received PBT were more likely to have advanced disease ( P < 0.001), high grade tumours ( P = 0.047) and nodal metastasis ( P = 0.004). PBT was associated with a higher risk of disease recurrence ( P = 0.003), cancer‐specific mortality ( P = 0.017), and any‐cause mortality ( P = 0.010) in univariable, but not multivariable, analyses ( P > 0.05). In multivariable analyses, pathological tumour stage, pathological nodal stage, soft tissue surgical margin, lymphovascular invasion and administration of adjuvant chemotherapy were independent predictors of disease recurrence, cancer‐specific mortality and any‐cause mortality (all P values <0.002). Conclusions Patients with UCB who underwent RC and received PBT had a greater risk of disease recurrence, cancer‐specific mortality and any‐cause mortality in univariable, but not multivariable, analysis. Although the greater need for PBT with more advanced disease is probably caused by a number of factors, including surgical and cancer‐related factors, the present analysis showed that the disease characteristics rather than need for PBT led to worse outcomes.
Computer Aided Quantification of Pathological Features for Flexor Tendon Pulleys on Microscopic Images
Liu, Yung-Chun , Chen, Hsin-Chen, Shih, Hui-Hsuan, Yang, Tai‐Hua , Yang, Hsiao‐Bai, Yang, Dee-Shan, Su, Fong‐Chin , Sun, Yung‐Nien , Yang, Hsiao‐Bai, Yang, Dee-Shan

Mayo Clinic

Computational and Mathematical Methods in Medicine | June 6, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-9

10.1155/2013/914124 | PMID 23840282 Get It

Quantifying the pathological features of flexor tendon pulleys is essential for grading the trigger finger since it provides clinicians with objective evidence derived from microscopic images. Although manual grading is time consuming and dependent on the observer experience, there is a lack of image processing methods for automatically extracting pulley pathological features. In this paper, we design and develop a color-based image segmentation system to extract the color and shape features from pulley microscopic images. Two parameters which are the size ratio of abnormal tissue regions and the number ratio of abnormal nuclei are estimated as the pathological progression indices. The automatic quantification results show clear discrimination among different levels of diseased pulley specimens which are prone to misjudgments for human visual inspection. The proposed system provides a reliable and automatic way to obtain pathological parameters instead of manual evaluation which is with intra- and interoperator variability. Experiments with 290 microscopic images from 29 pulley specimens show good correspondence with pathologist expectations. Hence, the proposed system has great potential for assisting clinical experts in routine histopathological examinations.
Multi-Institutional Study of Implantable Defibrillator Lead Performance in Children and Young Adults
Atallah, Joseph , Erickson, Christopher C. , Cecchin, Frank , Dubin, Anne M. , Law, Ian H. , Cohen, Mitchell I. , Cannon, Bryan C. , Freedenberg, Vicki , Gierdalski, Marcin , Berul, Charles I. , LaPage, Martin J , Chun, Terrence , Atallah, Joseph , Dubin, Anne M , Law, Ian H

Mayo Clinic

Circulation | May 21, 2013 | Volume: 127 | Issue: 24 | Pages: 2393-2402

10.1161/circulationaha.112.001120 | PMID 23694966 Get It

Background— Implantable cardioverter-defibrillator (ICD) therapy in children and congenital heart disease patients is hampered by poor long-term lead survival. Lead extraction is technically difficult and carries substantial morbidity. We sought to determine the outcomes of ICD leads in pediatric and congenital heart disease patients. Methods and Results— The Pediatric Lead Extractability and Survival Evaluation (PLEASE) is a 24-center international registry. Pediatric and congenital heart disease patients with ICD lead implantations from 2005 to 2010 were eligible. Study subjects comprised 878 ICD patients (44% congenital heart disease). Mean±SD age at implantation was 18.6±9.8 years. Of the 965 total leads, 54% were thin (≤7F), of which 57% were Fidelis, and 23% were coated with expanded polytetrafluoroethylene. There were 139 ICD lead failures (14%) in 132 patients (15%) at a mean lead age of 2.0±1.4 years, causing shocks in 53 patients (40%). Independent predictors of lead failure included younger implantation age and Fidelis leads. Actuarial analysis showed an incremental risk of lead failure with younger age at implantation: <8 years compared with >18 years ( P =0.015). The actuarial yearly failure rate was 2.3% for non-Fidelis and 9.1% for Fidelis leads. Extraction was performed on 143 leads (80% thin, 7% expanded polytetrafluoroethylene coated), with lead age as the only independent predictor for advanced extraction techniques. There were 6 major extraction complications (4%) but no procedural mortality. Conclusions— This study demonstrates that ICD leads in children and congenital heart disease patients have an age-related suboptimal performance, further compounded by a high failure rate of Fidelis leads. Advanced extraction techniques were common and correlated with older lead age. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT00335036.
Phenethyl isothiocyanate inhibits androgen receptor‐regulated transcriptional activity in prostate cancer cells through suppressing PCAF
Yu, Chun-Guang, Gong, Ai‐Yu, Chen, Dongqing , Leon, Daniel Solelo, Young, Charles YF, Chen, Xianming

Mayo Clinic

Molecular Nutrition & Food Research | May 10, 2013 | Volume: 57 | Issue: 10 | Pages: 1825-1833

10.1002/mnfr.201200810 | PMID 23661605 Get It

ScopeAndrogen receptor (AR) signaling is critical for all aspects of prostate growth and tumorigenesis. The glucosinolate‐derived phenethyl isothiocyanate (PEITC) has recently been demonstrated to reduce the risk of prostate cancer (PCa) and inhibit PCa cell growth. We previously reported that p300/CBP‐associated factor (PCAF), a co‐regulator for AR, is upregulated in PCa cells through suppression of the mir‐17 gene. Here, we assessed the effects of PEITC on PCAF expression and AR‐regulated transcriptional activity in PCa cells.Methods and resultsUsing AR‐responsive LNCaP cells, we observed the inhibitory effects of PEITC on the dihydrotestosterone‐stimulated AR transcriptional activity and cell growth of PCa cells. Interestingly, overexpression of PCAF attenuated the inhibitory effects of PEITC on dihydrotestosterone‐stimulated AR transcriptional activity. Expression of PCAF was upregulated in PCa cells through suppression of miR‐17. PEITC treatment significantly decreased PCAF expression and promoted transcription of miR‐17 in LNCaP cells. Functional inhibition of miR‐17 attenuated the suppression of PCAF in cells treated by PEITC.ConclusionOur results indicate that PEITC inhibits AR‐regulated transcriptional activity and cell growth of PCa cells through miR‐17‐mediated suppression of PCAF, suggesting a new mechanism by which PEITC modulates PCa cell growth.
Identification of Wasted Energy Is a Key to Predict Positive Response to Cardiac Resynchronization Therapy
Oh, Jae K. , Vatury, Ori, Wang, Chun-Li

Mayo Clinic

Circulation: Cardiovascular Imaging | March 19, 2013 | Volume: 6 | Issue: 2 | Pages: 159-161

10.1161/circimaging.113.000241 | PMID 23512777 Get It

Transcriptome Analysis of Garlic-Induced Hepatoprotection against Alcoholic Fatty Liver
Raghu, Rajasekaran , Liu, Chun-Ting, Tsai, Mong‐Hsun , Tang, Xiaojia , Kalari, Krishna R. , Subramanian, Subbaya , Sheen, Lee‐Yan , Kalari, Krishna R , Tang, Xiaojia

Mayo Clinic

Journal of Agricultural and Food Chemistry | October 15, 2012 | Volume: 60 | Issue: 44 | Pages: 11104-11119

10.1021/jf303800p | PMID 23066854 Get It

Abstract 5363: Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated antitumor efficacy in primary HCC cancer in vitro and in vivo
Shao, Huanjie , Tang, Haikuo, Zhang, Hao , Dy, Grace K. , Yu, Chunrong, Adjei, Alex A. , Roberts, Lewis R. , Gao, Chun , Roberts, Lewis R

Mayo Clinic

Cancer Research | June 27, 2012 | Volume: 71 | Issue: 8_Supplement | Pages: 5363-5363

10.1158/1538-7445.am2011-5363 Get It

Abstract The mammalian target of rapamycin (mTOR) consists of two distinct complexes, mTORC1 and mTORC2. mTOR plays a pivotal role in Hepatocellular Carcinoma (HCC). Previous studies indicated that inhibition of mTORC1 only moderately enhanced histone deacetylase inhibitors (HDACis)-mediated anti-tumor activity. This limited effect may be attributable to the increase of AKT activation through S6K1-IRS1-PI3K negative feedback loop triggered by selective mTORC1 inhibition. While as AKT is the downstream effector of mTORC2, we hypothesize that dual targeting of mTORC1/C2 would be more efficient in suppressing AKT and in enhancing anti-tumor activity of HDACi. In this study, the interactions between mTOR kinase inhibitors (mTORKis) and HDACis were examined in vitro using established HCC cell lines and in vivo using patient-derived HCC tumor xenografts on SCID mice. Our results demonstrate that inhibition of both mTORC1/2 not only effectively blocked mTORC1 signaling, but also abrogated negative-feedback activation of AKT caused by mTORC1 inhibition. Furthermore, inactivation of mTORC1/C2 by mTORKis substantially enhanced HDACi-induced anti-tumor activity. Either dysfunction of mTORC2 by knockdown of Rictor (a component of mTORC2), or diminution of AKT1 significantly lowered the threshold of HDACi-induced apoptosis. Lastly, in vivo study indicated that the combination of AZD8055 and Vorinostat yielded much greater tumor-growth inhibition compared to either agent alone in primary HCC xenografts without obvious adverse effects. Conclusion: Dual mTORC1/2 inhibition is more efficient than selective mTORC1 inhibition in enhancing anti-tumor activity of HDACi due to abrogation of negative-feedback activation of AKT induced by selective mTORC1 inhibition. Our findings suggest that combining regimen of mTORKi and HDACi may be an effective therapeutic strategy for HCC. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 5363. doi:10.1158/1538-7445.AM2011-5363
Circulating beta-atrial natriuretic factor in congestive heart failure in humans.
Wei, Chao , Lin, Junhong , Heublein, Denise M., Burnett, John C. , Kao, Pei-Chun , Schaff, Hartzell V.

Mayo Clinic

Circulation | June 12, 2012 | Volume: 88 | Issue: 3 | Pages: 1016-1020

10.1161/01.cir.88.3.1016 | PMID 8353863 Get It

BACKGROUND beta-Atrial natriuretic factor (beta-ANF) is an antiparallel dimer of alpha-ANF (alpha-ANF) with diminished cyclic GMP generation in vitro. To date, the presence of beta-ANF in the circulation of humans with severe congestive heart failure (CHF) remains controversial. The current study was designed to determine the presence and magnitude of circulating beta-ANF in severe CHF, to correlate plasma beta-ANF with the degree of ventricular dysfunction, and to investigate the role of human plasma and atrial tissue in the degradation of beta-ANF. METHODS AND RESULTS Venous plasma samples were obtained from patients (n = 12) with severe CHF and normal volunteers (n = 8). Total plasma ANF was measured by radioimmunoassay. alpha-ANF and beta-ANF in nonextracted plasma were separated by gel filtration chromatography using a P-6 column. Right atrial tissue samples (n = 5) were collected from a different group of patients at the time of open-heart surgery. 125I beta-ANF and I125 ANF were incubated with atrial tissue or plasma. The corresponding peak areas of beta-ANF were determined by Tamaya Digital Planimeter. beta-ANF represented 61% of total plasma ANF in CHF patients and was not detected in normal human plasma. The elevation of beta-ANF correlated with the severity of ventricular dysfunction. Thirty percent of beta-ANF and 100% alpha-ANF were converted to smaller peptide fragments in atrial tissue no conversion in plasma. CONCLUSIONS beta-ANF is the principal form of circulating ANF in patients with severe CHF and correlates with the degree of left ventricular dysfunction. beta-ANF is not generated from alpha-ANF and may be degraded rapidly in atrial tissue to smaller peptide fragments that do not occur in plasma. As beta-ANF is reported to have reduced biological action, the current studies may support the conclusion that the ANF system in CHF has reduced functional activity despite increases in circulation concentrations.